Hostname: page-component-586b7cd67f-vdxz6 Total loading time: 0 Render date: 2024-11-28T06:55:43.508Z Has data issue: false hasContentIssue false
  • English
  • Français

Evaluation of plasma fibronectine level as a probable indicator for tympanosclerosis

Published online by Cambridge University Press:  01 May 2007

K Görür ,
Ö Görüroğlu Öztürk ,
G Polat ,
Y Vayisoğlu ,
D Ü Talas ,
N Güner  and
C Özcan
K Görür*
Affiliation:
Departments of Otorhinolaryngology
Ö Görüroğlu Öztürk
Affiliation:
Biochemistry, Mersin University School of Medicine, Turkey
G Polat
Affiliation:
Biochemistry, Mersin University School of Medicine, Turkey
Y Vayisoğlu
Affiliation:
Departments of Otorhinolaryngology
D Ü Talas
Affiliation:
Departments of Otorhinolaryngology
N Güner
Affiliation:
Departments of Otorhinolaryngology
C Özcan
Affiliation:
Departments of Otorhinolaryngology
*
Address for correspondence: Dr Kemal Görür, Barbaros mah, Marina sit, C Blok, Kat 8, No: 16, Mersin, Turkey. Fax: +90 324 337 43 05 E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives:

Wound healing, epithelial regrowth and collagen synthesis are very important factors in the repair of the traumatised tympanic membrane. The aim of the present study was to determine the role of plasma fibronectine in the aetiopathogenesis of tympanosclerosis.

Methods:

This prospective study included 58 patients with and 49 without tympanosclerosis. No inflammation or trauma was noted in either patient group. All patients underwent otoscopic and otomicroscopic examination, and the degree of tympanosclerosis was graded from mild (stage I) to severe (stage III). Following otological examination, blood samples were taken for plasma fibronectine measurement.

Results:

Following otoscopic and otomicroscopic examinations, patients' tympanosclerosis was graded as follows: 18 patients were stage I; 29 were stage II; and 11 were stage III. Statistical analyses revealed that the plasma fibronectine concentrations were significantly lower in the study group compared with the control group (p = 0.031). In addition, fibronectine levels were lowest in the patients with severest tympanosclerosis (p = 0.0001 in each comparison).

Conclusion:

The results of the present study show that serum fibronectine is important in the development and severity of tympanosclerosis.

Keywords

TympanosclerosisFibronectineTympanic MembraneWound HealingExtracellular Matrix
Type
Main Article
Information
The Journal of Laryngology & Otology , Volume 122 , Issue 4 , April 2008 , pp. 343 - 346
Copyright
Copyright © JLO (1984) Limited 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1 Kay, D, Nelson, M, Rosenfeld, R. Meta-analysis of tympanostomy tube sequelae. Otolaryngol Head Neck Surg 2001;124:374–80Google Scholar
2 Tos, M, Bonding, P, Poulsen, G. Tympanosclerosis grommets. A prospective, comparative study. J Laryngol Otol 1993;97:489–96Google Scholar
3 Clement, B, Grimaud, JA, Campion, JP, Deugnier, Y, Guillouzo, AH. Cell types involved in collagen and fibronectin production in normal and fibrotic human liver. Hepatology 1986;6:225–33CrossRefGoogle ScholarPubMed
4 Kandemir, O, Polat, G, Sahin, E, Bagdatoglu, O, Camdeviren, H, Kaya, A. Fibronectin levels in chronic viral hepatitis and response of this protein to interferon therapy. Hepatogastroenterology 2004;51:811–14Google ScholarPubMed
5 Matsuda, M. Fibronectin – its functions and roles in tissue repair [in Japanese]. Nippon Geka Gakkai Zasshi 1994;85:882–6Google Scholar
6 Sakai, T, Johnson, KJ, Murozono, M, Sakai, K, Magnuson, MA, Weiloch, T et al. Plasma fibronectin supports neuronal survival and reduces brain injury following transient focal cerebral ischemia but is not essential for skin-wound healing and hemostasis. Nat Med 2001;7:324–30CrossRefGoogle Scholar
7 Bluestone, CD. Definitions, terminology, and classification. In: Rosenfeld, RM, Bluestone, CD, eds. Evidence-Based Otitis Media, 2nd edn. Hamilton & London: BC Decker, 2003;120–35Google Scholar
8 Singer, AJ, Clark, RAF. Cutaneous wound healing. N Engl J Med 1999;341:738–46Google Scholar
9 Koç, A, Uneri, C. Sex distribution in children with tympanosclerosis after insertion of a tympanostomy tube. Eur Arch Otorhinolaryngol 2002;258:16–19CrossRefGoogle Scholar
10 Koç, A, Üneri, C. Genetic predisposition for tympanosclerotic degeneration. Eur Arch Otorhinolaryngol 2002;259:180–3Google Scholar
11 Asiri, S, Hasham, A, Al Anazy, F, Zakzouk, S, Banyar, A. Tympanosclerosis: review of literature and incidence among patients with middle ear infection. J Laryngol Otol 1999;113:1076–80CrossRefGoogle ScholarPubMed
12 Dursun, G, Acar, A, Turgay, M, Çalguner, M. Human leucocyte antigens in tympanosclerosis. Clin Otolaryngol 1997;22:62–4CrossRefGoogle ScholarPubMed
13 Schiff, M, Yoo, IJ. Immunologic aspects of otologic disease. An overview. Laryngoscope 1985;95:256–69Google Scholar
14 Mattsson, C, Marklund, SL, Hellström, S. Application of oxygen free radical scavengers to diminish the occurrence of myringosclerosis. Ann Otol Rhinol Laryngol 1997;106:513–18CrossRefGoogle ScholarPubMed
15 Üneri, C, Sari, M, Akboğa, J, Yüksel, M. Vitamin E-coated tympanostomy tube insertion decreases the quantity of free radicals in tympanic membrane. Laryngoscope 2006;116:140–3Google Scholar
16 Wielinga, EW, Kerr, AG. Tympanosclerosis. Clin Otolaryngol Allied Sci 1993;18:341–9Google Scholar
17 Weilinga, EWJ, Peters, TA, Tonaer, ELGM, Kuijpers, W. Middle ear effusions and structure of the tympanic membrane. Laryngoscope 2001;111:90–5Google Scholar
18 Tos, M, Bounding, P, Poulsen, G. Tympanosclerosis of the drum in secretory otitis media. Acta Otolaryngol Suppl 1984;414:171–7Google Scholar
19 Görür, K, Özcan, C, Polat, A, Ünal, M, Tamer, L, Cinel, İ. The anti-oxidant and anti-apoptotic activities of selenium in the prevention of myringosclerosis in rats. J Laryngol Otol 2002;116:426–9Google Scholar
20 Akbaş, Y, Pata, YS, Görür, K, Polat, G, Polat, A, Özcan, C et al. The effect of L-carnitine on the prevention of experimentally induced myringosclerosis in rats. Hear Res 2003;184:107–12Google Scholar
21 Ozcan, C, Gorur, K, Cinel, L, Talas, DU, Unal, M, Cinel, I. The inhibitory effect of topical N-acetylcysteine application on myringosclerosis in perforated rat tympanic membrane. Int J Pediatr Otorhinolaryngol 2002;63:179–84CrossRefGoogle ScholarPubMed
22 Grinnell, F, Billingham, RE, Burgess, L. Distribution of fibronectin during wound healing in vivo. J Invest Dermatol 1981;76:181–9Google Scholar
23 Longaker, MT, Whitby, DJ, Ferguson, MWJ, Harrison, MR, Crombleholme, TM, Langer, JC et al. Studies in fetal wound healing: III early deposition of fibronectin distinguishes fetal from adult wound healing. J Pediatr Surg 1989;24:799–805Google Scholar
24 Laurent, C, Hellström, S. Extracellular matrix components reflect the dynamics of a healing tympanic membrane perforation – a histochemical study. Int J Biochem Cell Biol 1997;29:221–9CrossRefGoogle ScholarPubMed
25 Spandow, O, Hellstrom, S, Dahlstrom, M. Structural characterization of persistent tympanic membrane perforations in man. Laryngoscope 1996;106:346–52Google Scholar
26 Sade, J. Atelectatic tympanic membrane: histologic study. Ann Otol Rhinol 1993;102:712–16CrossRefGoogle ScholarPubMed
27 Clark, RA. Fibronectin matrix deposition and fibronectin receptor expression in healing and normal skin. J Invest Dermatol 1990;94:128–34SGoogle Scholar
28 Hellstrom, S, Bloom, GD, Berghem, L, Stenfors, LE, Soderberg, O. A comparison of hyaluronan and fibronectin in the healing of tympanic membrane perforations. Eur Arch Otorhinolaryngol 1991;248:230–5Google Scholar